Theator Raises $15.5M in Series A Funding


Theator, a Palo Alto, Calif.-based Surgical Intelligence platform leveraging AI and computer vision to improve surgeon performance, raised $15.5M in a Series A funding.

The round was led by Insight Partners, joined by new investor Blumberg Capital, and supported by all existing investors including NFX, StageOne Ventures, KdT Ventures, and iAngels and individual investors, including 23andMe’s Co-founder and CEO Anne Wojcicki, former Netflix Chief Product Officer Neil Hunt, and Zebra Medical Vision’s Co-founder Eyal Gura.

The company, which has raised a total of $18.5m to date, intends to use the funds to scale its commercial operations and partnerships with U.S. providers, and grow its R&D team.

Led by Dr. Tamir Wolf, CEO and Co-founder, Theator is a provider of AI-powered Surgical Intelligence solutions. Its platform is based on smart annotation and video analytics technology, which extracts and annotates key moments from surgical procedures, enabling surgeons to review operations and glean detailed insights within minutes. By identifying the most pivotal surgical steps, events, milestones, and ultimately decisions, the technology streamlines the pre-operative preparation and post-operative review and assessment process, significantly increasing surgeons’ performance, efficiency, and productivity.

To date, over a dozen medical centers have contributed to Theator’s comprehensive surgical video dataset, which now contains more than 400,000 minutes of curated surgical video encompassing over 80,000 intraoperative moments. The platform translates this video data into actionable feedback which surgeons can use to enhance performance.